business news in context, analysis with attitude

Yesterday, MNB took note of a Boston Globe report on the latest workout trend that seems to be gaining some traction, especially among young professionals: Pot, which apparently can help endurance and attitude.

I commented, in part:

I have to admit that I’m intrigued by by the notion that maybe it would help me deal with aching 63-year-old knees when I’m out for a run.

Which prompted one MNB reader to write:

Study after study from Stanford indicates the permanent effects marijuana has on short-term memory is devastating.   It seems to me that the Boston Globe story represents (at best) wishful thinking.
Brain health is a new area that many companies are exploring. As early as 2000, scientists at New York’s Cold Spring Harbor were working on a protein called CREB, which was believed to create an “on-switch” in the brain to connect neurons to build long term memory / focus. It has taken many years to get them past the FDA’s initial safety phase and ready for proof of concept studies. Acetyl L-Carnitine seems to be the closest ingredient to a memory / focus tool there is today.
All of which leads me to think that the FDA would have to undergo a similar process for approval.  I’d bet you are likely not to see the medical community approve this as a remedy for your 63-year-old knees.
Perhaps a swimming club membership is in order?


Regarding all the attention that Starbucks is getting for its anti-racial bias efforts, one MNB reader wrote:

I can’t help but wonder if all the news coverage surrounding Starbucks training isn’t the cheapest advertising that can be had.

Fair point.

I’d argue that there’s nothing wrong with getting attention for doing the right thing. And maybe it’ll counteract all the bad publicity it got when the events in Philadelphia transpired.
KC's View: